aTyr Pharma (“aTyr”), a biotherapeutics company involved in the discovery and clinical development of pioneering medicines for patients with…
Articles by Margarida Azevedo, MSc
BioMarin Pharmaceutical Inc., a company that develops and commercializes biopharmaceuticals for serious diseases and medical conditions, recently announced conclusion…
Clinical-stage biotechnology company Capricor Therapeutics, Inc. was recently awarded orphan drug designation for its investigational cell…
PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company that develops novel drugs to treat diabetes and cardiovascular dysfunction in patients suffering…
Clinical stage startup company Milo Biotechnology has begun treating the first Duchenne muscular dystrophy (DMD) patients with follistatin…
According to recent study, progressive myocardial fibrosis is associated with a decline in the left ventricular function in patients…
Sarepta Therapeutics has appointed Edward Kaye, MD, as its new interim Chief Executive Officer (CEO) to lead the effort…
In a clinical trial titled “…
In a recent study titled “Long Term Natural History Data in Ambulant Boys with Duchenne Muscular…
Patients in Indiana who suffer from terminal diseases such as muscular dystrophy may now have access to experimental…